Inflammation and tumor immune escape in response to DNA damage

Area of Science:

• Oncology
• Immunology
• Cell Biology

Background:

• Senescent and cancer cells exhibit shared inflammatory characteristics, including the senescence-associated secretory phenotype (SASP) and the cGAS-STING pathway.
• Tumor microenvironment inflammation influences cancer invasion, metastasis, and immune cell activity.
• PD-L1 expression, induced by inflammation, dictates the efficacy of immune checkpoint inhibitors (ICIs).

Purpose of the Study:

• To review the role of inflammation and immune escape mechanisms in cancer, particularly concerning DNA damage.
• To elucidate the involvement of the cGAS-STING pathway in inflammation-driven tumorigenesis and senescence.
• To highlight strategies for converting PD-L1-positive "cold" tumors into immunologically active "hot" tumors for improved ICI therapy.

Main Methods:

• Literature review focusing on inflammation, senescence, cancer, DNA damage, and the cGAS-STING pathway.
• Analysis of the interplay between inflammatory signaling and immune evasion in tumor development.
• Examination of PD-L1 expression and its implications for immunotherapy response.

Main Results:

• The cGAS-STING pathway is a critical regulator of inflammation in both senescent and cancer cells.
• Inflammation-induced PD-L1 expression in tumors affects ICI efficacy, with "cold" tumors showing poor response.
• "Hot" tumors, characterized by immune cell infiltration, respond better to ICIs, suggesting a need for therapeutic conversion.

Conclusions:

• Manipulating inflammatory responses is crucial for developing strategies to eliminate cancer via the innate immune system.
• Understanding the molecular mechanisms of inflammation-induced tumorigenesis, particularly via the cGAS-STING pathway, is essential for advancing cancer treatment.
• Converting PD-L1-positive "cold" tumors into "hot" tumors could significantly enhance the effectiveness of current immunotherapies.